354 related articles for article (PubMed ID: 26427660)
1. Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR).
Zhou Q; Chen J; Feng J; Wang J
Tumour Biol; 2016 Mar; 37(3):3105-13. PubMed ID: 26427660
[TBL] [Abstract][Full Text] [Related]
2. Effect of long non-coding RNA PVT1 on cell proliferation and migration in melanoma.
Chen L; Ma D; Li Y; Li X; Zhao L; Zhang J; Song Y
Int J Mol Med; 2018 Mar; 41(3):1275-1282. PubMed ID: 29286144
[TBL] [Abstract][Full Text] [Related]
3. BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.
Zheng H; Wang M; Jiang L; Chu H; Hu J; Ning J; Li B; Wang D; Xu J
Cancer Res Treat; 2016 Apr; 48(2):698-707. PubMed ID: 26323637
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA PVT1 promotes hepatocellular carcinoma progression through regulating miR-214.
Gou X; Zhao X; Wang Z
Cancer Biomark; 2017 Dec; 20(4):511-519. PubMed ID: 28800314
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PVT1 knockdown affects proliferation and apoptosis of uveal melanoma cells by inhibiting EZH2.
Huang XM; Shi SS; Jian TM; Tang DR; Wu T; Sun FY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2880-2887. PubMed ID: 31002139
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
8. lncRNA PVT1 promotes hepatitis B virus‑positive liver cancer progression by disturbing histone methylation on the c‑Myc promoter.
Jiang B; Yang B; Wang Q; Zheng X; Guo Y; Lu W
Oncol Rep; 2020 Feb; 43(2):718-726. PubMed ID: 31894346
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2.
Yang A; Wang H; Yang X
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046366
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b.
Zhang S; Zhang G; Liu J
APMIS; 2016 Aug; 124(8):649-58. PubMed ID: 27272214
[TBL] [Abstract][Full Text] [Related]
11. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer.
Sun Y; Ren D; Zhou Y; Shen J; Wu H; Jin X
Cell Death Dis; 2021 Sep; 12(10):878. PubMed ID: 34564701
[TBL] [Abstract][Full Text] [Related]
12. The expression and function of long noncoding RNA lncRNA-ATB in papillary thyroid cancer.
Fu XM; Guo W; Li N; Liu HZ; Liu J; Qiu SQ; Zhang Q; Wang LC; Li F; Li CL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3239-3246. PubMed ID: 28770959
[TBL] [Abstract][Full Text] [Related]
13. The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression.
Guo K; Yao J; Yu Q; Li Z; Huang H; Cheng J; Wang Z; Zhu Y
Tumour Biol; 2017 Apr; 39(4):1010428317699122. PubMed ID: 28381186
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA PVT1 facilitates cell proliferation by epigenetically regulating FOXF1 in breast cancer.
Guo G; Wang F; Han M; Gu Y; Duan X; Li L
RSC Adv; 2018 Jan; 8(5):2740-2750. PubMed ID: 35541468
[No Abstract] [Full Text] [Related]
15. Integrated bioinformatics analysis of chromatin regulator EZH2 in regulating mRNA and lncRNA expression by ChIP sequencing and RNA sequencing.
Li Y; Luo M; Shi X; Lu Z; Sun S; Huang J; Chen Z; He J
Oncotarget; 2016 Dec; 7(49):81715-81726. PubMed ID: 27835578
[TBL] [Abstract][Full Text] [Related]
16. EZH2-mediated suppression of lncRNA-LET promotes cell apoptosis and inhibits the proliferation of post-burn skin fibroblasts.
Zheng W; Yu A
Int J Mol Med; 2018 Apr; 41(4):1949-1957. PubMed ID: 29393360
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
18. EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.
Xue L; Yan H; Chen Y; Zhang Q; Xie X; Ding X; Wang X; Qian Z; Xiao F; Song Z; Wu Y; Peng Y; Xu H
BMC Cancer; 2019 Nov; 19(1):1094. PubMed ID: 31718595
[TBL] [Abstract][Full Text] [Related]
19. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
20. Expression of BANCR promotes papillary thyroid cancer by targeting thyroid stimulating hormone receptor.
Zheng H; Xu J; Hao S; Liu X; Ning J; Song X; Jiang L; Liu Z
Oncol Lett; 2018 Aug; 16(2):2009-2015. PubMed ID: 30034553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]